IJNRD Research Journal

WhatsApp
Click Here

WhatsApp editor@ijnrd.org
IJNRD
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 9

Issue Published : 96

Article Submitted :

Article Published :

Total Authors :

Total Reviewer :

Total Countries :

Indexing Partner

Join RMS/Earn 300

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: REVIEW ON DRUG CONTAINING HYDROGEL FOR THE TREATMENT OF CONJUNCTIVITIS
Authors Name: Dipak Raju Kale , Rohini kawar , Vaishnvi badak , Suresh waghmare , Ram Ingale
Download E-Certificate: Download
Author Reg. ID:
IJNRD_214755
Published Paper Id: IJNRD2403233
Published In: Volume 9 Issue 3, March-2024
DOI:
Abstract: Abstract: This review’s primary goal is to provide an overview of hydrogel-based conjunctivitis treatments. conventional medications including eye drops can be used under the present circumstances. Conventional drug forms such as eye drops have poor therapeutic responses and require regular dosage adjustments. Therefore, the pressing issue facing medical diligence investigators is creating a drug form that would carry the medication to the intended spot without significantly depleting the drug or producing any systemic side effects. (1) Around the world, conjunctivitis is a common ailment seen at ophthalmology conferences. Fearful signals have a greater number of serious intraocular disorders that need to be taken into consideration when treating presumed cases of conjunctivitis. These conditions correspond to significant pain (2), reduced vision and also patients with unusual anomalies and a history of eye conditions should also have an ocular examination. long-term duration. Findings from a concurrent physical examination and pertinent medical history may show involvement of the conjunctiva in an underlying illness. The definition of “hydrogel” refers to a type of polymeric compound whose hydrophilic structure allows them to retain enormous amounts of water that remain in their three-dimensional natural networks. In addition to other types of synthetic biomaterials, they remarkably resemble genuine living tissues because of they have contain large proportion of water, porosity, and soft viscosity. (3) To create a hydrogel that will lengthen a medicine’s retention period in an ocular pharmaceutical delivery method. In order to ensure the best possible bioavailability at the site of action, hydrogel ophthalmic doses made with HPMC have demonstrated excellent characteristics and a respectable sustained release profile. The conclusions of this investigation showed that using medications with hydrogel ophthalmic substances during eye care was effective. (4)
Keywords: Conjunctivitis, Disease, Hydrogel, Ophthalmology, Haemophilia’s’ influenza, Ocular etc.
Cite Article: "REVIEW ON DRUG CONTAINING HYDROGEL FOR THE TREATMENT OF CONJUNCTIVITIS", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.9, Issue 3, page no.c230-c247, March-2024, Available :http://www.ijnrd.org/papers/IJNRD2403233.pdf
Downloads: 00050
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2403233
Registration ID: 214755
Published In: Volume 9 Issue 3, March-2024
DOI (Digital Object Identifier):
Page No: c230-c247
Country: string:Aurangabad, string:Maharashtra, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2403233
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2403233
Share Article:
Share

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to Get DOI? DOI

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300

IJNRD